Michaelj Mcbreen News Today

Thomson Reuters consensus EPS estimate of $3.47. The company issued revenue guidance of $2.1 billion-$2.2 billion, compared to the consensus revenue estimate of $2.15 billion. The company updated its FY2023 earnings and revenue guidance.

Integra LifeSciences (NASDAQ:IART – Get Rating) had its price objective cut by Truist Financial from $54.00 to $44.00 in a report published on Tuesday morning, The Fly reports. A number of other equities analysts have also recently weighed in on IART. TheStreet cut Integra LifeSciences from a b- rating to a c+ rating in a […]

Citigroup downgraded shares of Integra LifeSciences (NASDAQ:IART – Get Rating) from a neutral rating to a sell rating in a research note issued to investors on Tuesday, The Fly reports. Citigroup currently has $39.00 price objective on the life sciences company’s stock, down from their previous price objective of $59.00. Several other brokerages also recently […]

Dimensional Fund Advisors LP decreased its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,203,527 shares of the life sciences company’s stock after selling 71,407 shares […]

22nd Century Group reaffirmed their downgrade rating on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report published on Tuesday morning, Benzinga reports. Several other equities research analysts have also recently commented on IART. Citigroup cut Integra LifeSciences from a neutral rating to a sell rating and lowered their price target for the […]

Integra LifeSciences (NASDAQ:IART – Get Rating)‘s stock had its “downgrade” rating reissued by 22nd Century Group in a research report issued to clients and investors on Tuesday, Benzinga reports. Other equities research analysts also recently issued reports about the company. StockNews.com began coverage on Integra LifeSciences in a research report on Thursday, May 18th. They […]

GW&K Investment Management LLC lessened its position in Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 0.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 764,638 shares of the life sciences company’s stock after selling 2,748 shares during the period. GW&K Investment Management LLC owned approximately […]

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating)’s share price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $39.00 and last traded at $40.12, with a volume of 393997 shares trading hands. The stock had previously closed at $40.48. Wall Street Analyst Weigh In Several research […]

Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $50.72, but opened at $44.80. Integra LifeSciences shares last traded at $45.16, with a volume of 782,620 shares trading hands. Analyst Ratings Changes IART has been the subject of several […]

StockNews.com began coverage on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report released on Thursday. The brokerage issued a buy rating on the life sciences company’s stock. A number of other brokerages also recently issued reports on IART. Truist Financial raised their price objective on Integra LifeSciences from $58.00 to $62.00 and […]